Drugs / Epleronone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT07539259 Comparator | Dec 2026 → Aug 2029 expected | aortic valve stenosis | University College, London | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT02034435 Comparator | Oct 2013 → Dec 2019 | metabolic syndrome X | Vanderbilt University Medical Center | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epleronone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02034435 ↗ |